Search hospitals > California > San Rafael
Kaiser San Rafael-Gallinas
Claim this profileSan Rafael, California 94903
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
102 reported clinical trials
6 medical researchers
Summary
Kaiser San Rafael-Gallinas is a medical facility located in San Rafael, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser San Rafael-Gallinas is involved with conducting 102 clinical trials across 293 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
33 reported clinical trials
97 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara2 years of reported clinical research
Studies Cancer
Studies Breast Cancer
22 reported clinical trials
63 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo7 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
20 reported clinical trials
51 drugs studied
Natalya Greyz-YusupovKaiser Permanente-Fresno4 years of reported clinical research
Studies Cancer
Studies Breast Cancer
5 reported clinical trials
10 drugs studied
Clinical Trials running at Kaiser San Rafael-Gallinas
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Squamous Cell Carcinoma
Follicular Lymphoma
Ovarian Cancer
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser San Rafael-Gallinas?
Kaiser San Rafael-Gallinas is a medical facility located in San Rafael, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser San Rafael-Gallinas is involved with conducting 102 clinical trials across 293 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.